Valiant Laboratories IPO Details: The scheduled date for Valiant Laboratories IPO has been confirmed. The IPO is set to enter the market on September 27th and conclude on October 3rd. The company aims to gather approximately ₹152 crores through this IPO. This sum includes a fresh issue of ₹152 crores via 11556000 shares, each valued at ₹10. The retail quota is 35%, while QIB is 50% and HNI is 15%.
What is Valiant Laboratories IPO?
Valiant Laboratories IPO is an initial public offering (IPO) of the company Valiant Laboratories Limited, which is a pharmaceutical ingredient manufacturing company based in Ahmedabad, India. The company manufactures a variety of pharmaceutical ingredients, including paracetamol, ibuprofen, and caffeine. It also provides contract manufacturing services for pharmaceutical products.
The Valiant Laboratories IPO is open for subscription from September 27 to October 3, 2023. The price band for the IPO is ₹133 to ₹140 per share. The minimum order quantity is 105 shares.
The company plans to use the proceeds from the IPO to set up a manufacturing facility for specialty chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd.
Key factors to consider before investing in the Valiant Laboratories IPO:
- The company is a leading player in the pharmaceutical ingredient manufacturing industry in India.
- It has a long track record of profitability and growth.
- The IPO proceeds will be used to fund the company’s growth plans.
- The company has a diversified product portfolio and a strong customer base.
However, investors should also be aware of the following risks:
- The company faces competition from other established players in the pharmaceutical ingredient manufacturing industry.
- The company’s business is cyclical and is dependent on the overall economic conditions.
- The company is exposed to risks such as foreign exchange fluctuations and changes in government regulations.
Overall, the Valiant Laboratories IPO is a good investment opportunity for investors looking to invest in a growing company with a strong track record. However, investors should carefully consider the risks involved before making an investment decision.
Objectives of Valiant Laboratories IPO
The objectives of the Valiant Laboratories IPO are as follows:
- To part-finance the setting up of a manufacturing facility for specialty chemicals in Gujarat through its subsidiary, Valiant Advanced Sciences Private Ltd.
- To fund the working capital requirements of the company.
- To meet general corporate purposes.
In other words, the company plans to use the proceeds from the IPO to expand its manufacturing capacity and product portfolio, improve its working capital requirements, and meet general corporate expenses.
Valiant Laboratories is a growing company with a strong track record. It is well-positioned to benefit from the growth of the Indian pharmaceutical industry and the increasing demand for specialty chemicals. The IPO is a good opportunity for investors to invest in a company with strong growth potential.
Valiant Laboratories IPO Date & Price Band Details
| IPO Open: | September 27, 2023 |
| IPO Close: | October 3, 2023 |
| IPO Size: | Approx ₹152 Crores |
| Fresh Issue: | Approx 11,556,000 shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹133 to ₹140 Per Share |
| IPO Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Discount: | N/A |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
Valiant Laboratories IPO Market Lot
The Valiant Laboratories IPO minimum market lot is 105 shares with ₹14,700 application amount. The retail investors can apply up-to 13 lots with 1365 shares or ₹191,100 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 105 | ₹14,700 |
| Retail Maximum | 13 | 1365 | ₹191,100 |
| S-HNI Minimum | 14 | 1470 | ₹205,800 |
| B-HNI Minimum | 69 | 7245 | ₹1,014,300 |
Valiant Laboratories IPO Allotment & Listing Dates
The Valiant Laboratories IPO date is September 27 and the close date is October 3. The Valiant Laboratories IPO allotment will be finalized on October 6 and the IPO listing on October 11.
| Anchor Investors Allotment: | September 26, 2023 |
| IPO Open Date: | September 27, 2023 |
| IPO Close Date: | October 3, 2023 |
| Basis of Allotment: | October 6, 2023 |
| Refunds: | October 9, 2023 |
| Credit to Demat Account: | October 10, 2023 |
| IPO Listing Date: | October 11, 2023 |
You can check this IPO calendar to have latest update on your mobile. Add this calendar to your mobile and get daily updates on the current and upcoming IPO.
Valiant Laboratories IPO Subscription Status
For the latest update on the Valiant Laboratories IPO, you can check this dedicated page for IPO subscription status.
Valiant Laboratories IPO Allotment Status
For the latest update on the Valiant Laboratories IPO, you can check this dedicated page for IPO allotment status.
Valiant Laboratories IPO Forms
For IPO form for the JSW Infrastructure IPO, you can check this dedicated page for IPO Forms.
Valiant Laboratories Company Financials
Valiant Laboratories Company Financials
Key Financials (2 Year Growth % p.a.)
FY21 FY22 FY23
Revenue (Rs Cr) 1823.69 2915.23 3339.10 (36.5%)
EBIT (Rs Cr) 230.74 423.72 526.08 (57.0%)
PAT (Rs Cr) 115.23 217.31 269.45 (69.7%)
Net Worth (Rs Cr) 325.56 442.89 535.11 (30.8%)
Key Highlights
- Revenue has grown at a CAGR of 36.5% over the past 2 years.
- EBIT has grown at a CAGR of 57.0% over the past 2 years.
- PAT has grown at a CAGR of 69.7% over the past 2 years.
- Net worth has grown at a CAGR of 30.8% over the past 2 years.
Overall, Valiant Laboratories has a strong financial performance with a healthy growth rate and a good balance sheet.
Please note that Valiant Laboratories is a relatively small company, so its financial data is not as easily available as that of a large company. The above financials are based on data from publicly available sources, such as the company’s prospectus and news reports.
Disclaimer: I am not a financial advisor and this is not financial advice. Please do your own research before making any investment decisions.
Valiant Laboratories IPO Pros & Cons
Pros
- Leading player in the pharmaceutical ingredient manufacturing industry
- Long track record of profitability and growth
- IPO proceeds will be used to fund the company’s growth plans
- Diversified product portfolio and a strong customer base
Cons
- Faces competition from other established players
- Business is cyclical and dependent on the overall economic conditions
- Exposed to risks such as foreign exchange fluctuations and changes in government regulations
- Relatively small company, so financial data is not as easily available as that of a large company
Additional thoughts
- The Valiant Laboratories IPO is a small and medium-sized enterprise (SME) IPO. SME IPOs are typically riskier than IPOs of large companies. Investors should carefully consider the risks involved before making an investment decision.
Company Promoters
- Shantilal Shivji Vora
- Dhanvallabh Ventures LLP
Valiant Laboratories IPO Registrar
Link Intime India Private Limited
Phone: +91 8108114949
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Company Address
Valiant Laboratories Limited
104, Udyog Kshetra, Mulund Goregaon Link Road,
Mulund West,
Mumbai -400080, Maharashtra
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: www.valiantlabs.in
Valiant Laboratories IPO FAQs
The IPO is set to enter the market on September 27th and conclude on October 3rd. The company aims to gather approximately ₹152 crores through this IPO.
The IPO will open on 27th September 2023.
There are two ways to apply for the Valiant Laboratories IPO:
Through a broker: This is the most common way to apply for an IPO. You will need to open a demat account with a broker if you do not already have one. Once you have a demat account, you can contact your broker to place your IPO application.
Through ASBA: ASBA stands for Application Supported by Blocked Amount. This is a method of applying for an IPO where the funds for your application are blocked in your bank account until the IPO is allotted. To apply for an IPO through ASBA, you will need to have a bank account that supports ASBA.
Here are the steps on how to apply for the Valiant Laboratories IPO through a broker:
Log in to your broker’s website or mobile app.
Go to the IPO section and select the Valiant Laboratories IPO.
Enter the number of shares you want to apply for and the price you are willing to pay.
Review your application and submit it.
If your application is successful, the funds for your application will be blocked in your bank account until the IPO is allotted. Once the IPO is allotted, the shares will be credited to your demat account.
Here are the steps on how to apply for the Valiant Laboratories IPO through ASBA:
Go to your bank’s website or mobile app.
Go to the ASBA section and select the Valiant Laboratories IPO.
Enter the number of shares you want to apply for and the price you are willing to pay.
Review your application and submit it.
Your bank will block the funds for your application in your bank account. Once the IPO is allotted, the shares will be credited to your demat account and the blocked funds will be released.
Please note that the eligibility criteria and application process for IPOs may vary from broker to broker. It is advisable to check with your broker for specific instructions on how to apply for the Valiant Laboratories IPO.
Also, please note that the Valiant Laboratories IPO is a small and medium-sized enterprise (SME) IPO. SME IPOs are typically riskier than IPOs of large companies. Investors should carefully consider the risks involved before making an investment decision.
Valiant Laboratories IPO size is ₹152 crores.
Valiant Laboratories IPO Price Band is ₹133 to ₹140.
Valiant Laboratories IPO allotment date is October 6, 2023.
Valiant Laboratories IPO listing date is October 11, 2023. The IPO is to list on BSE and NSE.